M
Mercè Brunet
Researcher at University of Barcelona
Publications - 103
Citations - 4090
Mercè Brunet is an academic researcher from University of Barcelona. The author has contributed to research in topics: Transplantation & Tacrolimus. The author has an hindex of 30, co-authored 98 publications receiving 3369 citations. Previous affiliations of Mercè Brunet include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.
Laura Vidal,Iván Victoria,Lydia Gaba,Marta Gil Martin,Mercè Brunet,Helena Colom,Marc Cortal,Mariana Gomez-Ferreria,Marc Yeste-Velasco,Antonio Perez,Jordi Rodon,Davendra Sohal,Jose M. Lizcano,Carles Domenech,Jose Alfon,Pere Gascón +15 more
TL;DR: ABTL0812 induces endoplasmic reticulum stress and blocks the Akt-mTOR axis; both actions converge to activate a robust and sustained autophagy leading to cancer cell death as mentioned in this paper.
Journal ArticleDOI
Prospective Study of Biomarkers of Immune Response in Lung Transplant Recipients
D. San Segundo,Mercè Brunet,M.A. Ballesteros,Olga Millán,Manuel Muro,M.J. Castro,Eduardo Miñambres,Marcos López-Hoyos +7 more
TL;DR: High Treg levels in the peripheral blood of lung transplant recipients were associated with an increased risk of rejection but not infection, and low levels of activated CD8 T cells in infected patients were observed.
Journal ArticleDOI
Pharmacodynamic Monitoring of mTOR Inhibitors
TL;DR: Current knowledge about PD biomarkers for personalized mTORi therapies seems promising, but before clinical implementation, the analytical methodologies must be standardized and cross-validated, and the selected biomarkers will have to demonstrate their clinical utility for SRL or EVR dose individualization in multicenter clinical trials.
Journal ArticleDOI
MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver Transplantation.
Pablo Ruiz,Olga Millán,José Ríos,José Ríos,Alba Díaz,Lydia Sastre,Jordi Colmenero,Gonzalo Crespo,Mercè Brunet,Miquel Navasa +9 more
TL;DR: In this article, the authors used miRNAs to diagnose T cell-mediated rejection after liver transplantation (LT) and compared their accuracy with previously published tests for diagnosing TCMR based on routine laboratory parameters.
Journal ArticleDOI
Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.
TL;DR: Atorvastatin proved to be an immunomodulatory agent, significantly decreasing lymphocyte proliferation, increasing ATP levels, and showing a trend toward increasing Treg cells in hypercholesterolemic patients, suggesting that the beneficial effects of atorVastatin in this patient group do not relate to immunoregulation.